Siegfried Holding

SFZN.SW Mid Cap

Healthcare · Drug Manufacturers - Specialty & Generic

Updated: Apr 5, 2026, 17:43 UTC

CHF 77.70

+0% today

52W: CHF 53.70 – CHF 101.60

52W Low: CHF 53.70 Position: 50.1% 52W High: CHF 101.60

🔗 Compare Brokers

Key Metrics

P/E Ratio

20.23x

Price-to-Earnings

Forward P/E

18.48x

Forward Price/Earnings

P/S Ratio

2.56x

Price-to-Sales

EV/EBITDA

12.57x

Enterprise Value/EBITDA

Div. Yield

51%

Annual dividend yield

Market Cap

$3.4B

Market Capitalization

Revenue Growth

YoY Revenue Growth

Profit Margin

12.7%

Net profit margin

ROE

15.98%

Return on Equity

Beta

0.79

Market sensitivity

Short Interest

—

% of float sold short

Avg. Volume

135,189

Average daily volume

Valuation Analysis

Signal

Fair

vs. S&P 500 avg P/E (24.7x)

Analyst Consensus

Buy

10 analysts

Avg. Price Target

CHF 104.60

+34.62% upside

Target Range

CHF 85.00 – CHF 126.00

About the Company

Siegfried Holding AG, together with its subsidiaries, engages in contract development and manufacturing of active pharmaceutical ingredient (API) and finished dosage forms worldwide. It offers drug substances, including exclusive synthesis that manufactures custom APIs. The company also offers an API portfolio, including non-exclusive APIs and pharma-grade substances that focus on anesthetics, pain and addiction treatment applications, and central nervous and respiratory diseases, as well as caffeine for human health and nutrition. In addition, it offers drug products, including steriles, which includes fill and finish in vials, ampoules, cartridges, and pre-filled syringes; ophthalmics, such as sterile ointments, gels, and suspensions and solutions; inhalation products, including capsules

Sector: Healthcare Industry: Drug Manufacturers - Specialty & Generic Country: Switzerland Employees: 3,891 Exchange: EBS